Sanofi sarilumab

Tuesday 01 January 2013

Sanofi sarilumab

Professor De Smet became the coordinator of the European study sarilumab for uveitis which do not adequately respond to the usual therapies. Sarilumab is a monoclonal antibody directed against the interleukin (IL)-6 receptor, a receptor involved in the inflammatory process.

read all